China steps up Alzheimer’s, Parkinson’s drug push, looks to TCM

AI Summary

China is intensifying its development of drugs targeting Alzheimer’s and Parkinson’s diseases in response to a rapidly aging population and increasing prevalence of these neurodegenerative conditions. The country plans to leverage traditional Chinese medicine as part of its health strategy to manage this escalating public health challenge.

To head off a public health crisis, China is stepping up efforts to find new treatments for Alzheimer’s disease and Parkinson’s disease. As its population ages, the country already has more cases of these neurodegenerative diseases than anywhere else in the world and their prevalence is rising faster than the global average. Cases of Parkinson’s disease in China are forecast to rise from 3.6 million in 2024 to 10.5 million in 2050, while the number of people in China with dementia is projected...